Reducing Frailty for Older Cancer Survivors Using Supplements
Reducing Frailty for Older Cancer Survivors Using Supplements
NCT ID: NCT04553666 Phase: PHASE2 Status: COMPLETED Enrollment: 24 Completion: 2023-08-31
Conditions
Frailty, Inflammation
Interventions
Epigallocatechin-3-Gallate (EGCG) plus Ascorbic Acid (Vitamin C)
Summary
The purpose of the study is to examine the feasibility and safety of twelve weeks oral supplementation of Epigallocatechin-3-gallate (EGCG) in older survivors of cancer
Primary Outcome
Recruitment Feasibility: Rates of Consent